<p>防御性投资在高飞的半导体反弹中被抛在了后面，许多个别行业落后于市场。</p>
<p>尽管在伊朗战争开始后经历了一次令人震惊的修正，标准普尔 500 指数目前年初至今（YTD）上涨约 10%。但这次反弹相对狭窄，市场在与人工智能相关的股票和没有人工智能相关的股票之间出现了明显分化，这使得保险行业处于危险境地。然而，并不是所有的保险股票都落后于市场。</p>
<p>事实上，一些股票正在创下 52 周新高，主要是因为它们避免了一个变得极具问题的市场细分：财产和意外险。</p>
<p>观察一对保险 ETF 可以看出市场的分化情况。iShares 美国保险 ETF NYSE: IAK 年初至今下跌约 2%，而 Invesco KBW 财产和意外险 ETF NASDAQ: KBWP 在 2026 年迄今下跌超过 5%。</p>
<p>商业财产和意外险定价是分化的主要原因。根据保险代理人和经纪人协会的数据，2026 年第一季度商业财产和意外险保费下降了 1.2%，这是自 2017 年以来首次出现保费价格下降的季度。财产保费受到的打击最大，下降了 5.8%，与前两个时期相比加速显著。</p>
<p>保险指数严重依赖于大型财产和意外险承保公司，如 Progressive Corp. NYSE: PGR、Chubb Ltd. NYSE: CB 和 Travelers Companies Inc. NYSE: TRV，这些公司正处于价格周期软化的瞄准范围内。但生命、团体福利和补充健康领域的公司则免受商业财产和意外险价格下跌的影响。在财产和意外险价格周期回落的同时，价值和福利行业仍然被低估，这正是我们将在这里探讨的股票选择领域。</p>
<p>在这个周期中挑选保险股票的关键主题是与商业财产和意外险领域的隔离。以下三家公司在财产和意外险方面的暴露较小，并且在主要指数中的存在有限（或没有）。</p>
<h2>大都会人寿：多元化复合型公司，强劲的股息</h2>
<p>大都会人寿公司 NYSE: MET 是这里唯一一只在指数中占有显著权重的保险股票（约占 IAK 持股的 5%），但不能因此归咎于其表现不佳。</p>
<p>MET 的股票在过去三个月上涨超过 17%，主要受到广泛的盈利超预期和股息增加的推动。</p>
<p>在公司于 5 月 6 日发布的 2026 年第一季度财报中，大都会人寿报告调整后收益为 16 亿美元，调整后每股收益为 2.42 美元，分别增长 18% 和 23%。公司还向股东回购和分红超过 10 亿美元。股息在增加后现在每年支付 2.37 美元，连续第 12 年增加。</p>
<p>该股票在最终突破约 83 美元的多年阻力位后也展现出动能。相对强弱指数（RSI）确认了看涨动能，表明这一突破可能具有持续性。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144032_met2026-06-0414-45-45.PNG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144032_met2026-06-0414-45-45.PNG"/></p>
<h2>Globe Life：深度价值逃离指数下跌</h2>
<p>Globe Life Inc. NYSE: GL 专注于为低收入和中等收入家庭提供生命和补充健康保险。</p>
<p>虽然中端市场的生命和补充保险并不是高增长行业，但它们确实提供稳定、长期的现金流，不易受到周期性影响。</p>
<p>该公司报告的 2026 年第一季度业绩大致符合市场预期，管理层将全年的运营每股收益指引上调至 15.40-15.90 美元。这里不需要一份爆炸性的报告，股票的交易仅为未来收益的 10 倍，远低于保险行业（12 倍收益）和标准普尔 500（22 倍收益）的水平。</p>
<p>图表也显示出一些积极的技术动能。现在 RSI 稳固在看涨区域，股票突破 50 日移动平均线可能是可持续的。以前的阻力区域在突破时往往会变成支撑，而 50 日移动平均线似乎成为 GL 股票的新分界线。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144353_gl2026-06-0414-47-30.PNG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144353_gl2026-06-0414-47-30.PNG"/></p>
<h2>Unum Group：低风险、高收益的就业保险公司</h2>
<p>Unum Group NYSE: UNM 尽管其稳定的就业相关和团体残疾承保公司（如 Colonial Life）未能在主要指数中占有一席之地，但它的表现值得关注。指数提供商可能想要纠正这个错误，因为这家公司可能是其中最具性价比的选择。</p>
<p>该股票的交易仅为未来收益的 9 倍和销售额的 1.06 倍，尽管在过去三个月上涨了 16%，受益于 2026 年第一季度的业绩超预期。收入同比增长 8%，主要得益于长期护理领域风险的减弱，管理层连续第 17 年提高了股息。</p>
<p>一家低贝塔的保险公司，拥有强劲的股息和去风险的叙述，就像价值投资者的飞蛾扑向灯光。该股票正处于健康的突破之中，创下新高，并在 50 日和 200 日移动平均线形成金叉。RSI 也在配合，保持其看涨水平而未突破超买阈值。这个低调的复合型机器可能会迎来更多新高。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144832_unm2026-06-0414-57-20.PNG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144832_unm2026-06-0414-57-20.PNG"/></p>
<h2>你现在应该投资 1000 美元在大都会人寿吗？</h2>
<p>在考虑大都会人寿之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场意识到之前购买……而大都会人寿并不在名单上。</p>
<p>尽管大都会人寿目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

UNUM保险

大都会人寿

<p>大都会人寿、Globe Life 和 UNUM 保险在 52 周内创下新高，因为在生命和健康保险领域的公司表现优于财产和意外险（P&C）公司。2026 年第一季度，商业 P&C 保费下降，拖累了以 P&C 为主的指数。相反，这三只股票受益于与 P&C 价格周期的隔离，报告了强劲的第一季度收益、股息增长和技术突破，使它们在市场分化中成为有吸引力的防御性投资</p>

<p>Defensive investing has been left in the dust by the high-flying semiconductor rally, and plenty of individual sectors are lagging the market.</p>
<div class="lb-trans"><p>防御性投资在高飞的半导体反弹中被抛在了后面，许多个别行业落后于市场。</p>
</div><p>Despite a whiplash-inducing correction following the start of the Iran war, the S&amp;P 500 is now up around 10% year-to-date (YTD). But the rally has been narrow, and the market has become sharply divided between stocks with AI connections and those without, which puts the insurance sector in perilous territory. However, not every insurance stock is lagging the market.</p>
<div class="lb-trans"><p>尽管在伊朗战争开始后经历了一次令人震惊的修正，标准普尔 500 指数目前年初至今（YTD）上涨约 10%。但这次反弹相对狭窄，市场在与人工智能相关的股票和没有人工智能相关的股票之间出现了明显分化，这使得保险行业处于危险境地。然而，并不是所有的保险股票都落后于市场。</p>
</div><p>In fact, some are making new 52-week highs, in large part because they’re avoiding a certain niche of the market that’s becoming highly problematic: property and casualty.</p>
<div class="lb-trans"><p>事实上，一些股票正在创下 52 周新高，主要是因为它们避免了一个变得极具问题的市场细分：财产和意外险。</p>
</div><p>A look into a pair of insurance ETFs shows where the market has become bifurcated. The iShares U.S. Insurance ETF NYSE: IAK is down about 2% YTD, but the Invesco KBW Property and Casualty ETF NASDAQ: KBWP is down more than 5% so far in 2026.</p>
<div class="lb-trans"><p>观察一对保险 ETF 可以看出市场的分化情况。iShares 美国保险 ETF NYSE: IAK 年初至今下跌约 2%，而 Invesco KBW 财产和意外险 ETF NASDAQ: KBWP 在 2026 年迄今下跌超过 5%。</p>
</div><p>Commercial P&amp;C pricing is the main culprit of the divergence. According to the Council of Insurance Agents and Brokers, commercial P&amp;C premiums fell 1.2% in Q1 2026, marking the first quarter of premium price declines since 2017. Property premiums took the biggest hit, dropping 5.8% in a “notable acceleration” from the previous two periods.</p>
<div class="lb-trans"><p>商业财产和意外险定价是分化的主要原因。根据保险代理人和经纪人协会的数据，2026 年第一季度商业财产和意外险保费下降了 1.2%，这是自 2017 年以来首次出现保费价格下降的季度。财产保费受到的打击最大，下降了 5.8%，与前两个时期相比加速显著。</p>
</div><p>The insurance indices are heavily weighted toward large-cap P&amp;C carriers like Progressive Corp. NYSE: PGR, Chubb Ltd. NYSE: CB, and Travelers Companies Inc. NYSE: TRV that sit in the crosshairs of the softening price cycle. But companies in the life, group benefits, and supplemental health segments are sheltered from commercial P&amp;C price declines. While the P&amp;C price cycle rolls over, the value and benefits industry continues to be undervalued, and that’s exactly the area we’re going to explore with our stock selections here.</p>
<div class="lb-trans"><p>保险指数严重依赖于大型财产和意外险承保公司，如 Progressive Corp. NYSE: PGR、Chubb Ltd. NYSE: CB 和 Travelers Companies Inc. NYSE: TRV，这些公司正处于价格周期软化的瞄准范围内。但生命、团体福利和补充健康领域的公司则免受商业财产和意外险价格下跌的影响。在财产和意外险价格周期回落的同时，价值和福利行业仍然被低估，这正是我们将在这里探讨的股票选择领域。</p>
</div><p>The key theme when picking insurance stocks in this cycle is insulation from the commercial P&amp;C segment. Each of the following three firms has little P&amp;C exposure and a limited (or no) presence in the major indices.</p>
<div class="lb-trans"><p>在这个周期中挑选保险股票的关键主题是与商业财产和意外险领域的隔离。以下三家公司在财产和意外险方面的暴露较小，并且在主要指数中的存在有限（或没有）。</p>
</div><h2>MetLife: Diversified Compounder With Strong Dividend</h2>
<div class="lb-trans"><h2>大都会人寿：多元化复合型公司，强劲的股息</h2>
</div><p>MetLife Inc. NYSE: MET is the only insurance stock listed here with a significant weight in the indices (about 5% of IAK’s holdings), but it can’t be blamed for the poor performance.</p>
<div class="lb-trans"><p>大都会人寿公司 NYSE: MET 是这里唯一一只在指数中占有显著权重的保险股票（约占 IAK 持股的 5%），但不能因此归咎于其表现不佳。</p>
</div><p>MET shares are up more than 17% in the last three months, driven by a broad earnings beat and dividend raise.</p>
<div class="lb-trans"><p>MET 的股票在过去三个月上涨超过 17%，主要受到广泛的盈利超预期和股息增加的推动。</p>
</div><p>In the company’s Q1 2026 numbers released on May 6, MetLife reported adjusted earnings of $1.6 billion and adjusted EPS of $2.42, up 18% and 23% respectively. The company also returned more than $1 billion to shareholders in buybacks and dividends. The dividend now pays $2.37 per share annually following the raise, the 12th consecutive year of payout increases.</p>
<div class="lb-trans"><p>在公司于 5 月 6 日发布的 2026 年第一季度财报中，大都会人寿报告调整后收益为 16 亿美元，调整后每股收益为 2.42 美元，分别增长 18% 和 23%。公司还向股东回购和分红超过 10 亿美元。股息在增加后现在每年支付 2.37 美元，连续第 12 年增加。</p>
</div><p>The stock also has momentum after finally breaking through a multi-year resistance level around $83. The Relative Strength Index (RSI) confirms the bullish momentum, indicating that this breakout could have staying power.</p>
<div class="lb-trans"><p>该股票在最终突破约 83 美元的多年阻力位后也展现出动能。相对强弱指数（RSI）确认了看涨动能，表明这一突破可能具有持续性。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144032_met2026-06-0414-45-45.PNG" alt="" original-src="https://www.marketbeat.com/logos/articles/med_20260604144032_met2026-06-0414-45-45.PNG"/></p>
<h2>Globe Life: Deep Value Escaping the Index Drawdown</h2>
<div class="lb-trans"><h2>Globe Life：深度价值逃离指数下跌</h2>
</div><p>Globe Life Inc. NYSE: GL focuses on life and supplemental health insurance for lower and middle-income households.</p>
<div class="lb-trans"><p>Globe Life Inc. NYSE: GL 专注于为低收入和中等收入家庭提供生命和补充健康保险。</p>
</div><p>While mid-market life and supplemental insurance aren’t high-growth industries, they do provide steady, long-duration cash flows that aren’t prone to cyclicality.</p>
<div class="lb-trans"><p>虽然中端市场的生命和补充保险并不是高增长行业，但它们确实提供稳定、长期的现金流，不易受到周期性影响。</p>
</div><p>The company reported Q1 2026 results approximately in line with market expectations, and management raised full-year operating EPS guidance to $15.40-$15.90. No need for a blowout report here, with the stock trading at just 10x forward earnings, a steep discount to both the insurance sector (12x earnings) and the S&amp;P 500 (22x earnings).</p>
<div class="lb-trans"><p>该公司报告的 2026 年第一季度业绩大致符合市场预期，管理层将全年的运营每股收益指引上调至 15.40-15.90 美元。这里不需要一份爆炸性的报告，股票的交易仅为未来收益的 10 倍，远低于保险行业（12 倍收益）和标准普尔 500（22 倍收益）的水平。</p>
</div><p>The chart is showing some positive technical momentum as well. Now that the RSI is firmly in bullish territory, the stock’s breakout above the 50-day moving average could be sustainable. Former resistance areas often become support during breakouts, and the 50-day MA appears to be a new line in the sand for GL shares.</p>
<div class="lb-trans"><p>图表也显示出一些积极的技术动能。现在 RSI 稳固在看涨区域，股票突破 50 日移动平均线可能是可持续的。以前的阻力区域在突破时往往会变成支撑，而 50 日移动平均线似乎成为 GL 股票的新分界线。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144353_gl2026-06-0414-47-30.PNG" alt="" original-src="https://www.marketbeat.com/logos/articles/med_20260604144353_gl2026-06-0414-47-30.PNG"/></p>
<h2>Unum Group: Low-Risk, High-Yield Employment Insurer</h2>
<div class="lb-trans"><h2>Unum Group：低风险、高收益的就业保险公司</h2>
</div><p>Unum Group NYSE: UNM also lacks representation in the major indices despite its steady franchise of employment-linked and group disability carriers, such as Colonial Life. Index providers may want to remedy this mistake, as this company may be the best bargain of the bunch.</p>
<div class="lb-trans"><p>Unum Group NYSE: UNM 尽管其稳定的就业相关和团体残疾承保公司（如 Colonial Life）未能在主要指数中占有一席之地，但它的表现值得关注。指数提供商可能想要纠正这个错误，因为这家公司可能是其中最具性价比的选择。</p>
</div><p>The stock trades at just 9x forward earnings and 1.06x sales despite a 16% gain over the last three months, boosted by a top- and bottom-line Q1 2026 earnings beat. Revenue grew 8% year-over-year (YOY), largely due to fading risk in the long-term care segment, and management boosted the dividend for the 17th consecutive year.</p>
<div class="lb-trans"><p>该股票的交易仅为未来收益的 9 倍和销售额的 1.06 倍，尽管在过去三个月上涨了 16%，受益于 2026 年第一季度的业绩超预期。收入同比增长 8%，主要得益于长期护理领域风险的减弱，管理层连续第 17 年提高了股息。</p>
</div><p>A low-beta insurer with a strong dividend and a derisking narrative is like a lightbulb for value-investing moths. The stock is in the midst of a healthy breakout, notching new all-time highs with a Golden Cross forming at the 50-day and 200-day MAs. The RSI is also cooperating, maintaining its bullish level without crossing the Overbought threshold. More highs are likely on the way for this under-the-radar compounding machine.</p>
<div class="lb-trans"><p>一家低贝塔的保险公司，拥有强劲的股息和去风险的叙述，就像价值投资者的飞蛾扑向灯光。该股票正处于健康的突破之中，创下新高，并在 50 日和 200 日移动平均线形成金叉。RSI 也在配合，保持其看涨水平而未突破超买阈值。这个低调的复合型机器可能会迎来更多新高。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144832_unm2026-06-0414-57-20.PNG" alt="" original-src="https://www.marketbeat.com/logos/articles/med_20260604144832_unm2026-06-0414-57-20.PNG"/></p>
<h2>Should You Invest $1,000 in MetLife Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在大都会人寿吗？</h2>
</div><p>Before you consider MetLife, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑大都会人寿之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场意识到之前购买……而大都会人寿并不在名单上。</p>
</div><p>While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管大都会人寿目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

这三只保险股创下 52 周新高：现在是否仍有购买的机会？